# ClinicalTrials.gov record NCT02706483

> PeptideScanner retained ClinicalTrials.gov record NCT02706483 at 2026-07-30T20:24:11.156Z. Its registry update date was 2020-08-18, and PeptideScanner's reviewed identity mapping was plecanatide.

- Evidence object: `story:clinicaltrials-gov-nct02706483-plecanatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2020-08-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02706483-plecanatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02706483-plecanatide-v1.json
- Content SHA-256: `6ed173296683f67a03688b5a3ca93bb4317f53752b3ac0993ed786059d910c57`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02706483 ([`ctg-observation-nct02706483-2020-08-18-6c58ce1f6e21`](#source-ctg-observation-nct02706483-2020-08-18-6c58ce1f6e21))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02706483 at 2026-07-30T20:24:11.156Z. Its registry update date was 2020-08-18, and PeptideScanner's reviewed identity mapping was plecanatide. ([`ctg-observation-nct02706483-2020-08-18-6c58ce1f6e21`](#source-ctg-observation-nct02706483-2020-08-18-6c58ce1f6e21))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02706483 at 2026-07-30T20:24:11.156Z. Its registry update date was 2020-08-18, and PeptideScanner's reviewed identity mapping was plecanatide. ([`ctg-observation-nct02706483-2020-08-18-6c58ce1f6e21`](#source-ctg-observation-nct02706483-2020-08-18-6c58ce1f6e21))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02706483-2020-08-18-6c58ce1f6e21`](#source-ctg-observation-nct02706483-2020-08-18-6c58ce1f6e21))

## Sources

<a id="source-ctg-observation-nct02706483-2020-08-18-6c58ce1f6e21"></a>
- **ClinicalTrials.gov record NCT02706483 · retained source version 2020-08-18:6c58ce1f6e211899e1a98ad916c9e8a0172d3b0d0d31a898dc3fcf5a0afc09f7** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02706483) (`ctg-observation-nct02706483-2020-08-18-6c58ce1f6e21`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02706483." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02706483-plecanatide-v1.json SHA-256: 6ed173296683f67a03688b5a3ca93bb4317f53752b3ac0993ed786059d910c57.